Primary Gross Tumor Volume is an Important Prognostic Factor in Locally Advanced Esophageal Cancer Patients Treated with Trimodality Therapy-Reference-Cited by-同舟云学术

Primary Gross Tumor Volume is an Important Prognostic Factor in Locally Advanced Esophageal Cancer Patients Treated with Trimodality Therapy

Published:2015-03-11 Issue:2 Volume:46 Page:131-137
ISSN:1941-6628
Container-title:Journal of Gastrointestinal Cancer
language:en
Short-container-title:J Gastrointest Canc

Author:

Boggs Drexell Hunter,Hanna Andrew,Burrows Whitney,Horiba Naomi,Suntharalingam Mohan

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s12029-015-9699-y.pdf

Reference28 articles.

1. Posner MC, Minsky BD, Ilson DH. Cancer of the esophagus. In: Devita VT, Lawrence TS, Rosenberg SA, editors. Cancer principles & practice of oncology. 9th ed. Philadelphia: Lippincott Williams & Wilkins; 2011. p. 887–923.

2. American Cancer Society Cancer facts & figures. American Cancer Society. 2012. http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2012/. Accessed 20 Sept 2013.

3. Howlader N, Noone AM, Krapcho M, et al. editors. SEER cancer statistics review, 1975–2009 (Vintage 2009 populations). Bethesda, MD: National Cancer Institute; 2012. 2012. http://seer.cancer.gov/csr/1975_2009_pops09/. Accessed on 20 Sept 2013.

4. Van Hagen P, Hulshof M, van Lanschot JJB, et al. Preoperative chemotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366:2074–84. doi:10.1056/NEJMoa1112088.

5. Gebski V, Burmeister B, Smithers BM, et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol. 2007;8:226–34. doi:10.1016/S1470-2045(07)70039-6.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimal Time-to-Surgery Recommendations Based on Primary Tumor Volume Regression for Patients with Resectable Esophageal Cancer after Neoadjuvant Chemoradiotherapy: A Retrospective Study;Annals of Surgical Oncology;2024-01-27

2. Esophageal stenosis as an independent factor of poor prognosis in patients with ESCC treated with definitive chemoradiotherapy;Future Oncology;2022-12

3. Prognostic values of the gross volume of metastatic lymph nodes in patients with esophageal squamous cell carcinoma treated with definitive concurrent chemoradiotherapy;Frontiers in Oncology;2022-11-10

4. Impact of Blood Parameters and Normal Tissue Dose on Treatment Outcome in Esophageal Cancer Patients Undergoing Neoadjuvant Radiochemotherapy;Cancers;2022-07-19

5. SCOPE 2 – Still Answering the Unanswered Questions in Oesophageal Radiotherapy? SCOPE 2: a Randomised Phase II/III Trial to Study Radiotherapy Dose Escalation in Patients with Oesophageal Cancer Treated with Definitive Chemoradiation with an Embedded Phase II Trial for Patients with a Poor Early Response using Positron Emission Tomography/Computed Tomography;Clinical Oncology;2022-07